Fatigue is more likely, affecting approximately 5% of users formally, though many more experience mild tiredness
Peptide Mapping In GLP-1 analogs (e.g., semaglutide, liraglutide), peptide mapping is used to confirm the sequence, modifications, and structure, for example a fatty acid side chain modification as well as amino acid sequence differences of the GLP-1 peptide chain in the case of Semaglutide (Figure 1) Figure 1: Structure of semaglutide showing differences to a native GLP-1 fragment sequence
According to an April 15 survey by healthcare company Tebra, more than a third of users of glucagon-like peptide-1 (GLP-1) receptor agonists are currently microdosing Ozempic and similar prescriptions, primarily due to the potential side effects associated with the drugs
Microdosing seems like a middle ground between being on a full dose and going off the med cold turkey
Not only would the way of taking the drug be easier for most, but the company also said the drug would be cheaper to manufacture
Academic Press: New York